SKN | Banco Santander Stock Recovers as AXA Ruling, Buybacks and UBS Target Shape the Outlook

Key Takeaways:

• Banco Santander shares fell 3.3% to €12.52 in Madrid on September 18, 2026, despite a UK Court of Appeal ruling that overturned a £677 million payout to AXA in a legacy payment protection insurance dispute.

• UBS reiterated a Buy rating with a €14.30 price target on September 21, while Santander continued its capital-return program with €558.9 million of shares repurchased between September 10 and September 16.

• Mexico remains an important growth component of the group strategy, with corporate loans in the market rising 11.3% between August 2025 and July 2026 according to the supplied source.

AXA Court Ruling Removes a Potential Liability

Banco Santander’s September 18 share-price decline came despite a potentially significant legal development. The UK Court of Appeal overturned a £677 million payout to AXA related to legacy payment protection insurance policies, limiting indemnity coverage to acts occurring after December 1, 2000.

The ruling removes the specific £677 million payout described in the source, but the market reaction was negative. Santander’s Madrid-listed shares closed at €12.52, down 3.3%, while its U.S. ADR ended at $14.34, a 3.27% decline from $14.82.

The divergence between the favorable legal outcome and the share-price reaction illustrates the difference between reducing a potential liability and generating an immediate positive market response. Investors were simultaneously assessing broader banking-sector conditions and the implications of Santander’s continuing capital-return program.

Buybacks Remain a Major Capital-Return Mechanism

Banco Santander repurchased €558.9 million of shares between September 10 and September 16, according to the supplied TradingView recap. The purchases represented approximately 30.6% of the authorized buyback cap cited in the source.

The broader program is substantial. The source states that Santander has repurchased approximately 18.2% of its shares outstanding since 2021. For wealth investors, buybacks are relevant because reducing the number of shares outstanding can affect per-share financial measures and the distribution of capital to remaining shareholders.

However, the market impact of buybacks depends on factors including the price paid for repurchased shares, capital generation, regulatory requirements and the bank’s ability to maintain its broader growth and investment plans.

UBS Maintains a €14.30 Price Target

UBS reiterated its Buy rating and €14.30 price target on September 21. Analyst Ignacio Cerezo noted that Santander’s U.S. auto securitization business weakened seasonally in August, although the decline was less pronounced than in the prior year.

Using the €12.52 September 18 closing price, the difference to the UBS target is approximately 14.2%. The source also cites a contemporaneous price around €12.72 in the UBS note, which produces a smaller gap. The distinction reflects different reference dates rather than a change in the stated target.

The UBS target should be treated as an analyst valuation benchmark rather than a guaranteed future price. The supplied material does not establish whether the target will be revised following subsequent earnings or changes in Santander’s operating environment.

Mexico Adds a Growth Dimension

Santander’s capital-return strategy is occurring alongside continued expansion in selected international markets. The supplied source reports that corporate loans in Mexico increased 11.3% between August 2025 and July 2026 as the bank adjusted its strategy to expand lending while maintaining risk discipline.

Mexico is therefore an important component of the group’s growth profile. The combination of lending expansion in Latin America, capital returns in Europe and the resolution of legacy legal exposures illustrates the multiple factors influencing Santander’s consolidated earnings and capital allocation.

Shares Show Early Recovery After the September 18 Decline

Intraday data cited in the source showed Santander trading around €12.71 on September 21, with a gain of approximately 1.52% against the previous close and an intraday range of €12.63 to €12.72. This represented a partial recovery from the €12.52 September 18 close.

The source also notes that Santander had gained more than 26% year to date despite the recent pullback. For private-wealth investors, that performance needs to be considered alongside the bank’s capital-return commitments, regional growth exposure, legal developments and the sensitivity of banking earnings to interest rates and credit conditions.

What Matters for Global Wealth Portfolios

Santander’s latest developments combine three distinct financial variables: the removal of a potential £677 million AXA liability, continued large-scale share repurchases and ongoing lending growth in Mexico. None should be viewed in isolation. The legal ruling affects risk exposure, buybacks affect capital allocation and per-share economics, while international loan growth influences the group’s future revenue and credit profile.

Closing Insights

Banco Santander’s September 18 decline occurred despite a favorable AXA court ruling and continued capital returns, while the September 21 recovery brought the stock closer to €12.70. UBS’s €14.30 target provides one external valuation reference, but the more durable signals for wealth investors will come from earnings, capital generation, credit performance and the bank’s ability to balance buybacks with growth across its international franchises.

For a confidential discussion regarding retail banking strategy, insurance distribution models, customer loyalty ecosystems, digital financial services, or cross-border financial innovation opportunities, contact our senior advisory team.